[一项新设计的跨导管中枢替换系统的动物研究结果]
1Department of Structure Heart Center, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming 650102, China.
Zhonghua xin xue guan bing za zhi
|March 17, 2025
概括
在羊的临床前研究中,TruDelta跨导管中关置换系统显示出有前途的生物相容性和耐用性. 结果表明成功的植入和良好的门功能与显著的内皮细胞化.
科学领域:
- 心血管研究的心血管研究.
- 生物材料科学是生物材料的科学.
- 手术方面的创新.
背景情况:
- 中心门疾病需要先进的治疗解决方案.
- 透导管 mitra 置换 (TMVR) 为手术修复提供了一种不那么侵入性的替代方案.
- 评估新型TMVR系统的生物相容性和耐用性对于临床转化至关重要.
研究的目的:
- 进行TruDeltaTM TMVR系统生物相容性和耐用性的初步评估.
- 为了评估TruDeltaTM设备在临床前动物模型中的性能和安全性.
主要方法:
- 六只成年绵羊接受了TruDeltaTM TMVR系统的跨细胞植入.
- 随访期间包括30天,90天和180天,并进行全面的心声回声评估.
- 尸体解剖后的分析包括粗体检查,血素-素染色,以及扫描电子显微镜的扩展门和组织.
主要成果:
- 所有6个TMVR手术都成功完成,没有任何并发症.
- 心声扫描证实了有效的门功能,具有最小的门外泄漏和有利的血液动力学参数 (梯度:7.8±3.2 mmHg,孔面积:1.8±0.2 cm2).
- 组织学和SEM分析显示,在90-180天内,内皮细胞有显著的内皮化 (>75%) 并没有结构失效.
结论:
- 在临床前的绵羊模型中,TruDeltaTM TMVR系统显示出有前途的生物相容性和耐用性.
- 这些发现支持TruDeltaTM器件在未来临床评估中在跨导管中枢置换中发挥的潜力.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...